GenoPalate, a leader in personalized nutrition, and WellSync, a telehealth platform focused on expanding access to modern weight management care, today announced an expanded partnership to bring personalized nutrition coaching to WellSync’s patient platform.
The collaboration comes as recent guidance from the World Health Organization reinforces that medication alone is not a complete solution to obesity. The WHO emphasizes that sustainable weight loss outcomes require a comprehensive approach that pairs medication with proper nutrition, regular movement, and ongoing, expert-led behavioral support.
Through this expanded partnership, WellSync patients will gain access to GenoPalate’s personalized coaching programs, including GLP-1–specific and non-prescription weight loss pathways. These programs are designed to support individuals at every stage of their journey, whether they are currently using GLP-1 medications, transitioning off medication, or do not qualify for the medicine.
GenoPalate’s coaching programs are tailored to each individual and can be further enhanced through the company’s multi-omic approach to personalization. Today, GenoPalate integrates genetic insights to inform nutrition guidance, with the ability to layer in blood biomarker analysis over time to deepen personalization and track progress.
“Medication plays an important role in weight loss, but it is not the full answer,” said Dr. Asif Naseem, Chief Executive Officer of GenoPalate. “Long-term success requires personalized nutrition, behavior change, and ongoing coaching. Our expanded partnership with WellSync allows us to bring that level of support directly into the telehealth experience, helping patients turn short-term progress into sustainable outcomes.”
“At WellSync, we are committed to delivering responsible, comprehensive care,” said Joe Rector, Chief Strategy Officer of WellSync. “By expanding our relationship with GenoPalate, we are giving patients access to personalized coaching and nutrition guidance that complements medication when appropriate and supports lasting success beyond the prescription.”
The expanded partnership reflects a shared commitment by GenoPalate and WellSync to advance evidence-based, personalized weight management solutions that prioritize long-term outcomes and patient success.
At GenoPalate, we empower individuals to take control of their lifelong wellness by gaining a comprehensive understanding of how their unique genetics and food habits influence their metabolic health. Through personalized recommendations, products, and coaching, we inspire enduring lifestyle changes that promote vibrant and sustained wellness.
About WellSync
WellSync is a telehealth platform focused on expanding access to personalized weight management care. By integrating medication management with nutrition, coaching, and lifestyle support, WellSync empowers patients with comprehensive tools to achieve and sustain meaningful results.
chris.connell@genopalate.com
GenoPalate
